ArticleJACS Au2026
Cascade MHAT Radical Cyclopentannulation of Skipped Enyne to Access Highly Functionalized Carbocycles.
Article in JACS Au, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
An iron-mediated metal-hydride hydrogen atom transfer (MHAT) radical cyclization cascade has been developed for the efficient construction of highly functionalized carbocyclic frameworks. This versatile [3+2] cyclopentannulation strategy starting from skipped enynes provides rapid access to a broad range of alkylidene cyclopentanes/cyclopentenes. Termination of this cascade with various radical trapping agents allows efficient construction of annulated products via successive C-H/C-C/C-C/C-X bond (X = C, H, S, Se, Te, I) formation. The method allows an expeditious entry into diquinanes, angular triquinanes with 4 quaternary carbons (3 contiguous) and substituted cyclopentadienes, all amenable to complex carbocycle synthesis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.